Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Structural Heart Disease: Same-day discharge after TAVR | MitraClip vs. surgical mitral valve replacement
Wednesday, April 13, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Same-day discharge after TAVR is feasible and safe, new Cleveland Clinic study confirms

Cleveland Clinic turned to same-day discharge after TAVR during the COVID-19 pandemic, finding considerable success. 

READ MORE >
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Share on Twitter Share on Facebook Share on Linkedin

Same-day discharge after TAVR is feasible and safe, new Cleveland Clinic study confirms

Share on Twitter Share on Facebook Share on Linkedin
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Cleveland Clinic turned to same-day discharge after TAVR during the COVID-19 pandemic, finding considerable success. 
READ MORE >

VIDEO: MitraClip vs. surgical mitral valve replacement

Joanna Chikwe, MD, founding chair of the department of cardiac surgery at Cedars-Sinai Hospital, compares transcatheter edge-to-edge repair (TEER) to mitral valve surgery for primary mitral regurgitation.

READ MORE >
MitraClip vs mitral valve edge to edge repair (TEER).
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: MitraClip vs. surgical mitral valve replacement

Share on Twitter Share on Facebook Share on Linkedin
MitraClip vs mitral valve edge to edge repair (TEER).
Joanna Chikwe, MD, founding chair of the department of cardiac surgery at Cedars-Sinai Hospital, compares transcatheter edge-to-edge repair (TEER) to mitral valve surgery for primary mitral regurgitation.
READ MORE >

How the continued rise of TAVR has impacted SAVR outcomes

Did SAVR outcomes suffer due to the rapid rise of TAVR? A team of researchers aimed to find out with a brand new analysis. 

READ MORE >
surgery.jpg
Share on Twitter Share on Facebook Share on Linkedin

How the continued rise of TAVR has impacted SAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
surgery.jpg
Did SAVR outcomes suffer due to the rapid rise of TAVR? A team of researchers aimed to find out with a brand new analysis. 
READ MORE >

VIDEO: Pascal effective in transcatheter repair of tricuspid valve regurgitation

Adam Greenbaum, MD, co-director of the Structural Heart and Valve Center at Emory University Hospital Midtown in Atlanta, explains details from the late-breaking CLASP TR trial at ACC.22.

READ MORE >
Adam Greenbaum, MD, Emory, explains the CLASP TR trial of the Pascal clip device for transcatheter repair, which was a late-breaking ACC22 study.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Pascal effective in transcatheter repair of tricuspid valve regurgitation

Share on Twitter Share on Facebook Share on Linkedin
Adam Greenbaum, MD, Emory, explains the CLASP TR trial of the Pascal clip device for transcatheter repair, which was a late-breaking ACC22 study.
Adam Greenbaum, MD, co-director of the Structural Heart and Valve Center at Emory University Hospital Midtown in Atlanta, explains details from the late-breaking CLASP TR trial at ACC.22.
READ MORE >

TAVR vs. surgery, FFR-guided PCI and DCB safety: Day 3 at ACC.22

Read our in-person coverage of the final day of ACC.22.

READ MORE >
ACC.22.jpg
Share on Twitter Share on Facebook Share on Linkedin

TAVR vs. surgery, FFR-guided PCI and DCB safety: Day 3 at ACC.22

Share on Twitter Share on Facebook Share on Linkedin
ACC.22.jpg
Read our in-person coverage of the final day of ACC.22.
READ MORE >

Older LAAO patients, especially women, face a higher risk of complications

Researchers explored data from the National Inpatient Sample, sharing their findings in the American Journal of Cardiology.

READ MORE >
Illustration of a left atrial appendage occlusion (LAAO) procedure using a Watchman device. Image courtesy of Johns Hopkins Medicine. #LAA #LAAO
Share on Twitter Share on Facebook Share on Linkedin

Older LAAO patients, especially women, face a higher risk of complications

Share on Twitter Share on Facebook Share on Linkedin
Illustration of a left atrial appendage occlusion (LAAO) procedure using a Watchman device. Image courtesy of Johns Hopkins Medicine. #LAA #LAAO
Researchers explored data from the National Inpatient Sample, sharing their findings in the American Journal of Cardiology.
READ MORE >

War in Ukraine has not stopped congenital heart surgeries in Kyiv

"We are staying strong," one surgeon told Cardiovascular Business. 

READ MORE >
 Oleksandr Yachnik, congenital heart surgeon at the Scientific Practical Children's Cardiac Center in Kyiv, Ukraine, performs a congential heart procedure while the Russians and the front lines are less than 10 miles away. #StandwithUkraine #Ukraine #RussianWarWithUkraine
Share on Twitter Share on Facebook Share on Linkedin

War in Ukraine has not stopped congenital heart surgeries in Kyiv

Share on Twitter Share on Facebook Share on Linkedin
 Oleksandr Yachnik, congenital heart surgeon at the Scientific Practical Children's Cardiac Center in Kyiv, Ukraine, performs a congential heart procedure while the Russians and the front lines are less than 10 miles away. #StandwithUkraine #Ukraine #RussianWarWithUkraine
"We are staying strong," one surgeon told Cardiovascular Business. 
READ MORE >

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief. 

READ MORE >
PCI can improve the odds of survival for some ischemic heart failure patients with moderate-to-severe functional mitral regurgitation, according to a new study. Image courtesy of Beaumont Hospital. Interventional cardiology procedure in a cath lab at Beaumont Hospital.
Share on Twitter Share on Facebook Share on Linkedin

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Share on Twitter Share on Facebook Share on Linkedin
PCI can improve the odds of survival for some ischemic heart failure patients with moderate-to-severe functional mitral regurgitation, according to a new study. Image courtesy of Beaumont Hospital. Interventional cardiology procedure in a cath lab at Beaumont Hospital.
Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme